Risk and prognostic factors in patients with colon cancer with liver metastasis

J Int Med Res. 2023 Sep;51(9):3000605231191580. doi: 10.1177/03000605231191580.

Abstract

Objective: The most common site of metastasis in patients with colon cancer is the liver. This study aimed to identify patients with colon cancer at high risk of developing liver metastasis and to explore their prognosis.

Methods: The clinical characteristics, treatment methods and survival outcomes of patients diagnosed with colon cancer from 2010 to 2015 were identified from the Surveillance, Epidemiology and End Results (SEER) database. Patients were divided into two groups according to the presence of liver metastasis, and multivariate logistic and Cox regression models were used to identify risk and prognostic factors.

Results: A total of 60,018 patients with colon cancer were selected from the SEER database. The incidence of liver metastasis was 9.2%. African American ethnicity, poor differentiation, higher tumor stage, higher lymph node ratio, and lung metastases were common factors associated with both liver metastasis risk and prognosis.

Conclusions: Metastasectomy might improve survival among patients with colon cancer with resectable liver metastasis lesions and no other organ involvement.

Keywords: Colon cancer; Epidemiology and End Results database; Surveillance; liver metastasis; prognosis; risk factor; survival.

MeSH terms

  • Black People / statistics & numerical data
  • Colonic Neoplasms* / epidemiology
  • Colonic Neoplasms* / mortality
  • Colonic Neoplasms* / pathology
  • Colonic Neoplasms* / therapy
  • Humans
  • Liver Neoplasms* / epidemiology
  • Liver Neoplasms* / mortality
  • Liver Neoplasms* / secondary
  • Liver Neoplasms* / therapy
  • Prognosis
  • Risk Factors
  • SEER Program / statistics & numerical data
  • United States / epidemiology